Alan Bruce Montgomery
Director/Board Member bei XENCOR, INC.
Vermögen: 110 805 $ am 31.03.2024
Profil
Alan Bruce Montgomery is the founder of Corus Pharma, Inc. (founded in 2001) and Cardeas Pharma Corp.
(founded in 2010).
He held the position of Chief Executive Officer at Corus Pharma, Inc. from 2001 to 2008 and Chief Executive Officer & Director at Cardeas Pharma Corp.
from 2012 to 2016.
Currently, he is the Lead Independent Director at Xencor, Inc. since 2015, Director at Vicis LLC, and Investment Committee Member at W Fund Management LLC.
He previously held positions such as Chief Executive Officer & Director at Avalyn Pharma, Inc. from 2017 to 2022, Independent Director at CytoDyn, Inc. from 2013 to 2018, and Senior Vice President-Respiratory Therapeutics at Gilead Sciences, Inc. from 2006 to 2011.
He also served as a Director at various companies such as ZymoGenetics, Inc., Geospiza, Inc., Athira Pharma, Inc., Light Sciences Corp., and Pacific Science Center.
Dr. Montgomery holds an undergraduate and doctorate degree from the University of Washington.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
XENCOR, INC.
0,01% | 20.06.2023 | 5 007 ( 0,01% ) | 110 805 $ | 31.03.2024 |
Aktive Positionen von Alan Bruce Montgomery
| Unternehmen | Position | Beginn |
|---|---|---|
| XENCOR, INC. | Director/Board Member | 18.03.2015 |
W Fund Management LLC
 W Fund Management LLC Investment ManagersFinance W Fund Management LLC (W Fund) is a venture capital firm founded in 2012 by Mr. Hamburg Robert. The firm is headquartered in Seattle, Washington. | Investment Committee Member | - |
Vicis LLC
 Vicis LLC Recreational ProductsConsumer Durables Vicis LLC designs and manufactures football helmets that mitigate linear and rotational impact forces. The company was founded by Samuel R. Browd, David L. Marver, Jonathan Posner and Per Reinhall in 2013 and is headquartered in Seattle, WA. | Director/Board Member | - |
Ehemalige bekannte Positionen von Alan Bruce Montgomery
| Unternehmen | Position | Ende |
|---|---|---|
Avalyn Pharma, Inc.
 Avalyn Pharma, Inc. Pharmaceuticals: MajorHealth Technology Avalyn Pharma, Inc. manufactures pharmaceutical products. It develops improved therapies for the treatment of idiopathic pulmonary fibrosis (IPF) and other severe respiratory diseases. The company was founded by Richard Glenn Vincent and Mark W. Surber in 2011 and is headquartered in Seattle, WA. | Chief Executive Officer | 14.10.2022 |
| ALDER BIOPHARMACEUTICALS, INC. | Director/Board Member | 01.01.2019 |
| CYTODYN INC. | Director/Board Member | 11.07.2018 |
Cardeas Pharma Corp.
 Cardeas Pharma Corp. Pharmaceuticals: MajorHealth Technology Cardeas Pharma Corp. develops drugs for the prevention of ventilator associated pneumonia. It offers a novel antibiotic formulation of two drugs with synergistic activity against relevant, resistant Gram-negative bacilli, including pseudomonas aeruginosa, acinetobacter baumannii, and carbapenem-resistant Enterobacteriaceae. The company was founded by Alan Bruce Montgomery on November 23, 2011 and is headquartered in Seattle, WA. | Founder | 01.01.2016 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01.05.2011 |
Ausbildung von Alan Bruce Montgomery
| University of Washington | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| CYTODYN INC. | Health Technology |
| XENCOR, INC. | Health Technology |
| ATHIRA PHARMA, INC. | Health Technology |
| Private Unternehmen | 13 |
|---|---|
PathoGenesis Corp
 PathoGenesis Corp BiotechnologyHealth Technology Part of Novartis AG, PathoGenesis Corp is a private company that develops and markets innovative treatments for chronic infectious diseases. The company is based in Seattle, WA. The company was founded by Isaac Blech. PathoGenesis was acquired by Chiron Corp. on September 19, 2000 for $639.75 million. | Health Technology |
ZymoGenetics, Inc.
 ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Health Technology |
Corus Pharma, Inc.
 Corus Pharma, Inc. Pharmaceuticals: MajorHealth Technology Corus Pharma, Inc. develops drugs to treat needs in infectious diseases and respiratory areas. The firm's core competencies reside in the identification of drugs, rapid clinical development, and FDA approval of its products. The firm was founded in January 2001 by A. Bruce Montgomery and is headquartered in Seattle, WA. | Health Technology |
Geospiza, Inc.
 Geospiza, Inc. Packaged SoftwareTechnology Services Geospiza, Inc. develops enterprise-class software systems for workflow management of genetic analysis. It makes software for crunching the vast amounts of genetic data. The firm's products include GeneSifter analysis edition and lab edition which provide integrated solutions for genetic analysis to help researchers and core lab managers focus on the science. The company was founded by Todd M. Smith and Robert Arnold in 1997 and is headquartered in Seattle, WA. | Technology Services |
Cardeas Pharma Corp.
Cardeas Pharma Corp. Pharmaceuticals: MajorHealth Technology Cardeas Pharma Corp. develops drugs for the prevention of ventilator associated pneumonia. It offers a novel antibiotic formulation of two drugs with synergistic activity against relevant, resistant Gram-negative bacilli, including pseudomonas aeruginosa, acinetobacter baumannii, and carbapenem-resistant Enterobacteriaceae. The company was founded by Alan Bruce Montgomery on November 23, 2011 and is headquartered in Seattle, WA. | Health Technology |
Avalyn Pharma, Inc.
Avalyn Pharma, Inc. Pharmaceuticals: MajorHealth Technology Avalyn Pharma, Inc. manufactures pharmaceutical products. It develops improved therapies for the treatment of idiopathic pulmonary fibrosis (IPF) and other severe respiratory diseases. The company was founded by Richard Glenn Vincent and Mark W. Surber in 2011 and is headquartered in Seattle, WA. | Health Technology |
Light Sciences Corp.
 Light Sciences Corp. Pharmaceuticals: MajorHealth Technology Light Sciences Corp. was manufactured biopharmaceuticals and biotherapeutics products. The company was founded in 1995 and was headquartered in Snoqualmie, WA. | Health Technology |
| Washington Biotechnology & Biomedical Association | |
Lundbeck Seattle BioPharmaceuticals, Inc.
 Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lundbeck Seattle BioPharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on transforming the migraine treatment paradigm through the discovery, development and commercialization of novel therapeutic antibodies. Its product includes Eptinezumab, is an investigational monoclonal antibody (mAb) that inhibits calcitonin gene-related peptide (CGRP) and is currently in late-stage clinical development for the prevention of migraine. The company was founded by Randall C. Schatzman, Mark J. Litton, and John A. Latham in January 2004 and is headquartered in Bothell, WA. | Health Technology |
Pacific Science Center
 Pacific Science Center Other Consumer ServicesConsumer Services Pacific Science Center operates as a science museum. The non-profit company is based in Seattle, WA. William T. Daugherty has been the CEO of the company since 2016. | Consumer Services |
Life Sciences Discovery Fund
 Life Sciences Discovery Fund Miscellaneous Commercial ServicesCommercial Services Life Sciences Discovery Fund provides research in the Washington state to promote life sciences competitiveness. The firm offers commercialization of health-related technologies, economic development in Washington state, improving health and health care in Washington state. The company was founded in 2005 and is headquartered in Seattle, WA. | Commercial Services |
W Fund Management LLC
W Fund Management LLC Investment ManagersFinance W Fund Management LLC (W Fund) is a venture capital firm founded in 2012 by Mr. Hamburg Robert. The firm is headquartered in Seattle, Washington. | Finance |
Vicis LLC
Vicis LLC Recreational ProductsConsumer Durables Vicis LLC designs and manufactures football helmets that mitigate linear and rotational impact forces. The company was founded by Samuel R. Browd, David L. Marver, Jonathan Posner and Per Reinhall in 2013 and is headquartered in Seattle, WA. | Consumer Durables |
